UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition

International journal of molecular sciences, 2023-02, Vol.24 (5), p.4331

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of the COVID‐19 Pandemic in Mexican Patients with Thoracic Malignancies

The oncologist (Dayton, Ohio), 2021-12, Vol.26 (12), p.1035-1043

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations

BMC cancer, 2020-09, Vol.20 (1), p.829-829, Article 829

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

Frontiers in oncology, 2020-09, Vol.10, p.570233-570233

2020

Link zum Volltext

Verfügbarkeit prüfen

LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer

Current oncology (Toronto), 2022-12, Vol.30 (1), p.333-343

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma

Frontiers in oncology, 2021-04, Vol.11, p.641975-641975

2021

Link zum Volltext

Verfügbarkeit prüfen

Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical Trial

The oncologist (Dayton, Ohio), 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population

Lung cancer (Amsterdam, Netherlands), 2022-12, Vol.174, p.133-140

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes

Clinical & translational oncology, 2024-04, Vol.26 (4), p.836-850

2024

Link zum Volltext

Verfügbarkeit prüfen

Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index

Cancer medicine (Malden, MA), 2023-01, Vol.12 (1), p.146-158

2023

Link zum Volltext

Verfügbarkeit prüfen

Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial

International journal of radiation oncology, biology, physics, 2023-03, Vol.115 (3), p.592-607

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1127: Effect of the combined therapy of sotorasib and metformin in non-small cell lung cancer cell lines

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1127-1127

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of KRAS G12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes

Clinical & translational oncology, 2024-04, Vol.26 (4), p.836

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-05-36: Cost-effectiveness of CDK4/6 inhibitors as a First line Therapy for Metastatic Breast Cancer. A Mexican Cohort

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P6-P6-05-36

2023

Link zum Volltext

Verfügbarkeit prüfen

GuÃa de prÃ¡ctica clÃnica para el manejo del cÃ¡ncer de pulmÃ³n de cÃ©lulas pequeÃ±as: enfermedad extensa

Gaceta Mexicana de oncología, 2023-04, Vol.22 (2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Guía de práctica clínica para el manejo del cáncer de pulmón de células pequeñas: enfermedad extensa

Gaceta mexicana de oncología, 2023-06, Vol.22 (2), p.55-73

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a risk-sharing agreement for atezolizumab treatment in second- and third-line NSCLC patients: A strategy in order to improve access in low income countries

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18683-e18683

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1078: Sotorasib and metformin combination enhances cytotoxicity and apoptosis in KRAS mutant lung cancer cell lines

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1078-1078

2023

Link zum Volltext

Verfügbarkeit prüfen

Implementing Standard Diagnosis and Treatment for Locally Advanced Breast Cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial

JCO global oncology, 2024-05, Vol.10 (10), p.e2300216

2024

Link zum Volltext

Verfügbarkeit prüfen

Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women

Frontiers in oncology, 2022-03, Vol.12, p.845527-845527

2022

Link zum Volltext

Verfügbarkeit prüfen

Rapid Recurrence of Helicobacter pylori Infection in Peruvian Patients after Successful Eradication

Clinical infectious diseases, 1997-11, Vol.25 (5), p.1027-1031

1997

Link zum Volltext

Verfügbarkeit prüfen

Chronic Atrophic Gastritis: Early Diagnosis in a Population Where Helicobacter pylori Infection Is Frequent

Clinical infectious diseases, 1997-11, Vol.25 (5), p.1006-1012

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Oncology
(12)
Humans
(11)
Mutation
(8)
Female
(7)
Lung Cancer
(6)
Middle Aged
(6)
Aged
(5)
Cancer Therapies
(5)
Adult
(4)
Breast Cancer
(4)
Male
(4)
Patients
(4)
Carcinoma, Non-Small-Cell Lung - Genetics
(3)
Chemotherapy
(3)
Erbb Receptors - Genetics
(3)
Lung Neoplasms - Genetics
(3)
Medical Prognosis
(3)
Prognosis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition

Clinical Impact of the COVID‐19 Pandemic in Mexican Patients with Thoracic Malignancies

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer

Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma

Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical Trial

A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population

Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes

The Evolution of Clinically Aggressive Triple-Negative Breast Cancer Shows a Large Mutational Diversity and Early Metastasis to Lymph Nodes

Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index

Comprehensive Genomic Profile of Heterogeneous Long Follow-Up Triple-Negative Breast Cancer and Its Clinical Characteristics Shows DNA Repair Deficiency Has Better Prognostic

Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial

Abstract 1127: Effect of the combined therapy of sotorasib and metformin in non-small cell lung cancer cell lines

Impact of KRAS G12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes

Abstract P6-05-36: Cost-effectiveness of CDK4/6 inhibitors as a First line Therapy for Metastatic Breast Cancer. A Mexican Cohort

GuÃa de prÃ¡ctica clÃnica para el manejo del cÃ¡ncer de pulmÃ³n de cÃ©lulas pequeÃ±as: enfermedad extensa

Guía de práctica clínica para el manejo del cáncer de pulmón de células pequeñas: enfermedad extensa

Evaluation of a risk-sharing agreement for atezolizumab treatment in second- and third-line NSCLC patients: A strategy in order to improve access in low income countries

Abstract 1078: Sotorasib and metformin combination enhances cytotoxicity and apoptosis in KRAS mutant lung cancer cell lines

Implementing Standard Diagnosis and Treatment for Locally Advanced Breast Cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial

Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women

Rapid Recurrence of Helicobacter pylori Infection in Peruvian Patients after Successful Eradication

Chronic Atrophic Gastritis: Early Diagnosis in a Population Where Helicobacter pylori Infection Is Frequent

Suchergebnisse filtern